We revealed that Hexo could transfer hypoxia-induced resistance to gemcitabine in normoxic PC cells, dedifferentiate them into a cancer stem-like state, and reduce their drug sensitivity to gemcitabine. The gene discussed is ERI1; the disease is cancer.